Dr Alan Shaw at Calysta's Teesside facility. '“I want to commend our team in the UK for achieving this significant milestone,' he said.

Fishmeal replacement location revealed

The site of a facility that will be able to produce up to 200,000 tonnes of fishmeal replacement a year for the global aquafeed industry has been unveiled today (29/11/16). 

Published Last updated

The gas fermentation facility, which will be a joint venture between Cargill and Calysta, will be built on the former’s 69-acre property on President’s Island. The facility is expected to come online in late 2018, producing up to 20,000 metric tonnes per year of Calysta’s FeedKind protein initially and expanding up to 200,000 metric tonnes per year when operating at full capacity.

Upon completion of the plant, the new venture expects to hire 75 permanent employees and expand to 160 people when the plant is at full ramp-up.

“Cargill has been a part of the Memphis community for 40 years. With the strong support of the state of Tennessee, Shelby County and City of Memphis, we are pleased that the venture chose to locate the facility in Memphis,” said Cargill’s Global Vice President of Bioindustrial, Brian Silvey. “The venture’s building of a state-of-the-art fermentation facility on the existing Cargill Memphis site reaffirms our commitment to the community and state and our pledge to strategically invest in aquaculture as an ever increasingly important source of protein.”

About Feedkind

FeedKind protein is a proprietary, competitively priced, new feed ingredient initially targeted as an alternative to fishmeal for the aquaculture industry. It is produced using the world’s only commercially validated gas fermentation process and will be marketed jointly by Cargill and Calysta.

“With a proven and proprietary fermentation platform, Calysta is introducing a scalable and disruptive protein source critical to meeting the needs of a growing global population. Partnering with Cargill, a leader in fermentation and protein production, and others to invest in the establishment of the venture as the first US manufacturing plant to commercially produce FeedKind protein, significantly accelerates FeedKind protein’s launch in the aquaculture industry at commercial scale. This venture is an important first step to deploying this technology globally,” said Calysta President and Chief Executive Officer, Alan Shaw.

In September 2016, Calysta opened an R&D and market introduction facility in the United Kingdom to produce samples of FeedKind protein that can be used in aquaculture, livestock and pet markets worldwide.